Patent Assignment
Reel/Frame 026376/0076
Merger
Recorded: 2011-05-31
Received: 2011-05-31
Pages: 21
Assignor
ALCON, INC.
Executed: 2011-04-08
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, CHX, CH-4056, SWITZERLAND
Covered Properties
(100)
Intraocular Lenses with Combinations of Uv Absorbers and Blue Light Chromophores
Application:
13/095,031 →
Rnai-Mediated Inhibition of Frizzled Related Protein-1 for Treatment of Glaucoma
Application:
13/084,944 →
Ophthalmic Compositions Containing a Synergistic Combination of Two Polymers
Application:
13/083,823 →
Optical Structures with Nanostructre Features and Methods of Use and Manufacture
Application:
61/472,948 →
Adjustable Chromophore Compounds and Materials Incorporating Such Compounds
Application:
13/076,665 →
Adjustable Intraocular Lens System
Application:
13/075,239 →
Accommodating Intraocular Lens Using Trapezoidal Phase Shift
Application:
13/042,688 →
Control of Intraocular Pressure Using ALK5 Modulation Agents
Application:
13/042,848 →
Agents for Treatment of Glaucomatous Retinopathy and Optic Neuropathy
Application:
13/031,742 →
Low-Tack, Hydrophobic Ophthalmic Device Materials
Application:
61/440,633 →
Method of Treating Dry Eye Disorders and Uveitis
Application:
13/022,692 →
RNAi-MEDIATED INHIBITION OF SELECT RECEPTOR TYROSINE KINASES FOR TREATMENT OF PATHOLOGIC OCULAR NEOVASCULARIZATION-RELATED CONDITIONS
Application:
13/019,655 →
Visible Light Absorbers for Ophthalmic Lens Materials
Application:
13/008,409 →
Uv-Absorbers for Ophthalmic Lens Materials
Application:
13/004,373 →
Monitoring Thermal Conditions to Vary Operation of an Ultrasonic Needle Tip of a Surgical Instrument
Application:
12/984,196 →
Intraocular Lens Transfer Case
Application:
61/424,883 →
Correction of Higher Order Aberrations in Intraocular Lenses
Application:
12/971,125 →
Superoxide Dismutase Mimics For The Treatment Of Optic Nerve And Retinal Damage
Application:
12/971,143 →
Agents Which Regulate, Inhibit, or Modulate the Activity and/or Expression of Connective Tissue Growth Factor (Ctgf) as a Unique Means to Both Lower Intraocular Pressure and Treat Glaucomatous Retinopathies/Optic Neuropathies
Application:
12/970,662 →
Aspheric Optical Lenses and Associated Systems and Methods
Application:
61/423,475 →
Rnai-Mediated Inhibition of Ocular Hypertension Targets
Application:
12/967,121 →
5,6,7-Trihydroxyheptanoic Acid and Analogs for the Treatment of Ocular Diseases and Diseases Associated with Hyperproliferative and Angiogenic Responses
Application:
12/967,141 →
Intraocular devices and associated methods
Application:
12/960,653 →
Graphical User Interface for Phacoemulsification Surgical System
Application:
12/951,656 →
Devices and Methods for Holding an Intraocular Lens During the Processing and Packaging of the Intraocular Lens
Application:
12/945,184 →
Statins for the Treatment of Ocular Hypertension and Glaucoma
Application:
12/941,639 →
Intraocular lens
Application:
12/940,422 →
Uv-Absorbers for Ophthalmic Lens Materials
Application:
12/915,990 →
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
Application:
12/912,061 →
Phase-shifted center-distance diffractive design for ocular implant
Application:
12/910,446 →
RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS
Application:
12/901,019 →
Topical Nepafenac Formulations
Application:
12/888,631 →
Combination of Viscoelastics for Use During Surgery
Application:
12/887,017 →
System for Dissociation and Removal of Proteinaceous Tissue
Application:
12/881,302 →
Controlling A Phacoemulsification Surgical System By Transitioning Between Pulse and Burst Modes
Application:
12/875,249 →
Torsional Ultrasound Hand Piece That Eliminates Chatter
Application:
12/875,461 →
Method of Controlling a Surgical System Based on a Rate of Change of an Operating Parameter
Application:
12/875,304 →
Intraocular Lenses with Interlenticular Opacification Resistance
Application:
12/874,863 →
Ophthalmic and Otorhinolaryngological Device Materials
Application:
12/861,454 →
Use of Inhibitors of Jun N-Terminal Kinases to Treat Glaucoma
Application:
12/858,739 →
Truncated diffractive intraocular lenses
Application:
12/847,214 →
Footswitch Operable to Control a Surgical System
Application:
12/836,961 →
Use of Inhibitors of Jun N-Terminal Kinases for the Treatment of Glaucomatous Retinopathy and Ocular Diseases
Application:
12/831,702 →
Uv/Visible Light Absorbers for Ophthalmic Lens Materials
Application:
12/830,087 →
Visible Light Absorbers for Ophthalmic Lens Materials
Application:
12/830,149 →
Surgical Variable-Angle Illuminator
Application:
12/828,725 →
Ophthalmic Compositions Containing Polysaccharide-Borate Gelling System
Application:
12/827,731 →
High Refractive Index, Acrylic Ophthalmic Device Materials with Reduced Glistenings
Application:
61/356,963 →
Lens Delivery System
Application:
12/792,898 →
Method of Controlling a Surgical System Based on Irrigation Flow
Application:
12/793,293 →
System and Method for Illumination Attenuation
Application:
12/787,811 →
Methods of Using Zinc Containing Compounds to Improve Ocular Health
Application:
12/782,057 →
Iol with Varying Correction of Chromatic Aberration
Application:
12/780,381 →
Zonal Diffractive Multifocal Intraocular Lens with Central Monofocal Diffractive Region
Application:
12/780,244 →
Intra-Ocular Device with Multiple Focusing Powers/Optics
Application:
12/776,807 →
Intraocular lens
Application:
12/775,094 →
Aminopyrazine Analogs for Treating Glaucoma and Other Rho Kinase-Mediated Diseases and Conditions
Application:
12/774,399 →
Superoxide Dismutase Mimics for the Treatment of Ocular Disorders and Diseases
Application:
12/766,332 →
A Method of Treating Glaucoma Comprising Administering a Composition Comprising Human BMP7
Application:
12/766,056 →
System and Method of Non-Invasive Continuous Level Sensing Using a Linear Sensor Array
Application:
12/760,032 →
Surgical Cassette for Intraocular Pressure Control
Application:
12/750,787 →
Superoxide Dismutase Mimics for the Treatment of Ocular Disorders and Diseases
Application:
12/730,820 →
Multi-Led Ophthalmic Illuminator
Application:
12/728,782 →
Lens surface with combined diffractive, toric, and aspheric components
Application:
12/723,939 →
Dual Function Uv-Absorbers for Ophthalmic Lens Materials
Application:
12/722,185 →
3,6-Substituted Imidazol[1,2-B]Pyridazine Analogs for Treating Allergic and Inflammatory Diseases
Application:
12/720,808 →
Compounds with 5-HT1A Activity Useful for Treating Disorders of the Outer Retina
Application:
12/719,152 →
USE OF AGENTS THAT DOWN-REGULATE EXPRESSION OF TANIS AND/OR P21 Waf1/Cip1/Sd1 GENES, AND USE OF AGENTS THAT INHIBIT, DEGRADE, SEQUESTER OR PREVENT THE NEUROTOXICITY OF GENE PRODUCT PROTEINS OF TANIS AND P21 Waf1/Cip1/Sd1 GENES
Application:
12/719,144 →
Agents for Treatment of Diabetic Retinopathy and Drusen Formation in Macular Degeneration
Application:
12/715,853 →
Method of Measuring Diffractive Lenses
Application:
12/702,076 →
Accommodative Intraocular Lens System
Application:
12/699,967 →
Single optic accommodative intraocular lens system
Application:
12/699,279 →
Smart Illumination for Surgical Devices
Application:
12/693,808 →
Method of Controlling a Surgical System Based on a Load on the Cutting Tip of a Handpiece
Application:
12/691,879 →
Ophthalmic and Otorhinolaryngological Device Materials Containing a Reactive Nvp Macromer
Application:
12/687,277 →
Ophthalmic and Otorhinolaryngological Device Materials Containing a Multi-Arm Peg Macromer
Application:
12/687,322 →
Method Of Controlling A Surgical System Based On Irrigation Flow
Application:
12/683,191 →
Use of Cooling Agents to Relieve Mild Ocular Irritation and Enhance Comfort
Application:
12/645,690 →
Use of Serum Amyloid a Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents
Application:
12/638,072 →
Intraocular lens with extended depth of focus
Application:
12/634,026 →
Surgical laser system with remote control functionality
Application:
12/634,150 →
Diffractive multifocal intraocular lens with modified central distance zone
Application:
12/621,613 →
Use of Serum Amyloid a Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents
Application:
12/617,795 →
Trocar cannula
Application:
12/616,172 →
Radially Segmented Apodized Diffractive Multifocal Design for Ocular Implant
Application:
12/614,752 →
Apodized aspheric diffractive lenses
Application:
12/611,945 →
Uv/Visible Light Absorbers for Ophthalmic Lens Materials
Application:
12/611,539 →
Histone Deacetylase Inhibitors for the Treatment of Ocular Neovascular or Edematous Disorders and Diseases
Application:
12/609,873 →
Accommodating intraocular lens
Application:
12/578,713 →
Rnai Inhibition of Ctgf for Treatment of Ocular Disorders
Application:
12/577,267 →
Method of Controlling a Surgical System Based on a Load on the Cutting Tip of a Handpiece
Application:
12/577,521 →
Implantable Drug Delivery System
Application:
12/575,573 →
System to Reduce Surface Contact Between Optic and Haptic Areas
Application:
12/573,446 →
Microsurgical probe
Application:
12/559,997 →
Inhibitors of Glycogen Synthase Kinase-3 (Gsk-3) for Treating Glaucoma
Application:
12/545,611 →
Aspiration Control via Flow or Impedance
Application:
12/545,392 →
RNAi-Mediated Inhibition of Ocular Targets
Application:
12/536,698 →
Ophthalmic Device Having Therapeutic Agent Delivery Capability and Method of Forming Same
Application:
12/505,558 →
Extended Depth of Focus (Edof) Lens to Increase Pseudo-Accommodation by Utilizing Pupil Dynamics
Application:
12/503,267 →
Accommodative IOL with Toric Optic and Extended Depth of Focus
Application:
12/503,307 →